B-type natriuretic peptide (BNP) was shown to proceed symptoms development in patients with AS and predict prognosis [7–9] and indeed, BNP levels are included in clinical guideline for AVR in asymptomatic AS patients and low surgical risk. This evidence concerns the gene NPPB and aortic valve stenosis.